Find the matching chart
If a Wegovy pen is not working properly, discard it without using it
Conclusion Semaglutide represents a promising option for individuals looking to manage their weight effectively
Efficacy and Safety of Semaglutide Compared with Liraglutide and Placebo for Weight Loss in Patients with Obesity: A Randomised, Double-blind, Placebo and Active Controlled, Dose-ranging, Phase 2 Trial. The Lancet, 390(10100), 898-907
By promoting satiety, it supports sustainable weight loss
It is unknown whether WEGOVY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions ( 5.1 ), Nonclinical Toxicology ( 13.1 )]